Dechra Pharmaceuticals (DPH) Share Price, News & Analysis

Company Overview

Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, internal medicine, and nutrition products supporting cats and dogs with various therapeutic conditions, such as allergies, obesity, heart, and kidney diseases. It also provides water soluble antibiotics, vaccines, lameness, pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies. In addition, the company distributes veterinary pharmaceuticals and equipment; markets pet diets; and develops, regulates, manufactures, and markets crop protection, as well as offers financial services. It markets its products through wholesaler and distributor networks. The company operates in the United Kingdom, Germany, rest of Europe, the United States, and internationally. Dechra Pharmaceuticals PLC was incorporated in 1997 and is headquartered in Northwich, the United Kingdom.

Key Stats

• Today's Range: 3,866 to 3,866
• 50-Day Range: 3,866 to 3,866
• 52-Week Range: 2,473.32 to 4,145.84
• Volume: 2.04 million shs
• Average Volume: 1.29 million shs
• Market Capitalization: £4.40 billion
• P/E Ratio: N/A
• Dividend Yield: 1.16%
• Price Target: N/A
• Consensus Rating: N/A

DPH Stock Analysis - Frequently Asked Questions

How have DPH shares performed this year?

Dechra Pharmaceuticals' stock was trading at GBX 3,858 at the beginning of 2024. Since then, DPH shares have increased by 0.2% and is now trading at GBX 3,866.
View the best growth stocks for 2024 here.

How do I buy shares of Dechra Pharmaceuticals?

Shares of DPH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Dechra Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Dechra Pharmaceuticals investors own include 32Red (TTR), 1428686 (SGP.L) (SGP), JD Sports Fashion (JD), Ashtead Group (AHT), Cranswick (CWK), Drax Group (DRX) and RPC Group (RPC).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Drug Manufacturers - General
• Sub-Industry: Personal Services
• Current Symbol: LON:DPH
• CUSIP: N/A
• CIK: N/A
• Web: www.dechra.com
• Phone: +44-1606-814730
• Fax: N/A
• Employees: 2,457
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (0.25)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 20.41
• P/E Growth: 1.42
• Net Income: £-27,900,000.00
• Net Margins: -3.66%
• Pretax Margin: N/A
• Return on Equity: -3.92%
• Return on Assets: 0.75%

Debt

• Debt-to-Equity Ratio: 66.80
• Current Ratio: 2.85
• Quick Ratio: 1.66

Sales & Book Value

• Annual Sales: £761.50 million
• Price / Sales: 5.78
• Cash Flow: GBX 158.24 per share
• Price / Cash Flow: 24.43
• Book Value: GBX 663 per share
• Price / Book: 5.83

Miscellaneous

• Outstanding Shares: 113,910,000
• Free Float: N/A
• Market Cap: £4.40 billion
• Optionable: Not Optionable
• Beta: 0.78